|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-1-18
|
|
pubmed:abstractText |
Acute renal failure is a frequent complication of sepsis. Hydroxyethyl starch (HES) is widely used in the treatment of such patients. However, the effect of HES on renal function during sepsis remains controversial. We established an in vitro model of tumor necrosis factor-alpha (TNF-alpha)-stimulated human proximal tubular epithelial (HK-2) cells to assess the possible effects of HES 130/0.42 and HES 200/0.5 on these activated cells.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorescein-5-isothiocyanate,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorescent Dyes,
http://linkedlifedata.com/resource/pubmed/chemical/Gelatin,
http://linkedlifedata.com/resource/pubmed/chemical/Hetastarch,
http://linkedlifedata.com/resource/pubmed/chemical/Isotonic Solutions,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Plasma Substitutes,
http://linkedlifedata.com/resource/pubmed/chemical/Ringer's lactate,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/physiogel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1526-7598
|
|
pubmed:author |
pubmed-author:Beck-SchimmerBeatriceB,
pubmed-author:BooyChristaC,
pubmed-author:BurmeisterMarc-AlexanderMA,
pubmed-author:De ConnoElisenaE,
pubmed-author:KWANTESC M SCM,
pubmed-author:ReyesLiviaL,
pubmed-author:SchimmerRalph CRC,
pubmed-author:SchläpferMartinM,
pubmed-author:SeifertBurkhardtB,
pubmed-author:SpahnDonat RDR,
pubmed-author:Z'graggenBirgit RothBR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
531-40
|
|
pubmed:dateRevised |
2010-5-28
|
|
pubmed:meshHeading |
pubmed-meshheading:19910630-Cell Line,
pubmed-meshheading:19910630-Cell Survival,
pubmed-meshheading:19910630-Cells, Cultured,
pubmed-meshheading:19910630-Chemokine CCL2,
pubmed-meshheading:19910630-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19910630-Epithelial Cells,
pubmed-meshheading:19910630-Fluorescein-5-isothiocyanate,
pubmed-meshheading:19910630-Fluorescent Dyes,
pubmed-meshheading:19910630-Gelatin,
pubmed-meshheading:19910630-Hetastarch,
pubmed-meshheading:19910630-Humans,
pubmed-meshheading:19910630-Inflammation,
pubmed-meshheading:19910630-Isotonic Solutions,
pubmed-meshheading:19910630-Kidney Tubules, Proximal,
pubmed-meshheading:19910630-L-Lactate Dehydrogenase,
pubmed-meshheading:19910630-Microscopy, Confocal,
pubmed-meshheading:19910630-Plasma Substitutes,
pubmed-meshheading:19910630-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The effect of hydroxyethyl starches (HES 130/0.42 and HES 200/0.5) on activated renal tubular epithelial cells.
|
|
pubmed:affiliation |
Institute of Anesthesiology, University of Zurich, Zurich, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
